Elevate your fundraising game with Will Rosellini's expertise. Learn the art of strategic fundraising, optimizing capital structures, and aligning operations with investor expectations. Follow the masterclass for success in venture capital. Visit website:- https://www.willrosellini.com/
Will Rosellini is the President of CytoImmune Therapeutics, a clinical stage biotechnology company. Previously, he was Chief Executive Officer of Perimeter Medical and, prior to that, Chief Executive Officer of Nexeon Medsystems, a medical device manufacturing company that went public in 2017.
